Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Guidance on the use of the benchmark dose approach in risk assessment

Open access
EFSA Scientific Committee, More, Simon John, Bampidis, Vasileios, Benford, Diane, Bragard, Claude, Halldorsson, Thorhallur Ingi, Hernández‐Jerez, Antonio F, Bennekou, Susanne Hougaard, Koutsoumanis, Kostas, Lambré, Claude, Machera, Kyriaki, Mennes, Wim, Mullins, Ewen, Nielsen, Søren Saxmose, Schrenk, Dieter, Turck, Dominique, Younes, Maged, Aerts, Marc, Edler, Lutz, Sand, Salomon, Wright, Matthew, Binaglia, Marco, Bottex, Bernard, Abrahantes, Jose Cortiñas, Schlatter, Josef · 2022 · EFSA Journal

Abstract

The Scientific Committee (SC) reconfirms that the benchmark dose (BMD) approach is a scientifically more advanced method compared to the no-observed-adverse-effect-level (NOAEL) approach for deriving a Reference Point (RP). The major change compared to the previous Guidance (EFSA SC, 2017) concerns the Section 2.5, in which a change from the frequentist to the Bayesian paradigm is recommended. In the former, uncertainty about the unknown parameters is measured by confidence and significance levels, interpreted and calibrated under hypothetical repetition, while probability distributions are attached to the unknown parameters in the Bayesian approach, and the notion of probability is extended to reflect uncertainty of knowledge. In addition, the Bayesian approach can mimic a learning process and reflects the accumulation of knowledge over time. Model averaging is again recommended as the preferred method for estimating the BMD and calculating its credible interval. The set of default models to be used for BMD analysis has been reviewed and amended so that there is now a single set of models for quantal and continuous data. The flow chart guiding the reader step-by-step when performing a BMD analysis has also been updated, and a chapter comparing the frequentist to the Bayesian paradigm inserted. Also, when using Bayesian BMD modelling, the lower bound (BMDL) is to be considered as potential RP, and the upper bound (BMDU) is needed for establishing the BMDU/BMDL ratio reflecting the uncertainty in the BMD estimate. This updated guidance does not call for a general re-evaluation of previous assessments where the NOAEL approach or the BMD approach as described in the 2009 or 2017 Guidance was used, in particular when the exposure is clearly lower (e.g. more than one order of magnitude) than the health-based guidance value. Finally, the SC firmly reiterates to reconsider test guidelines given the wide application of the BMD approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2903/j.efsa.2022.7584

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 222

Metadata

Authors
EFSA Scientific Committee, More, S. J., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T. I., Hernández‐Jerez, A. F., Bennekou, S. H., Koutsoumanis, K., Lambré, C., Machera, K., Mennes, W., Mullins, E., Nielsen, S. S., Schrenk, D., Turck, D., Younes, M., Aerts, M., Edler, L., Sand, S., Wright, M., Binaglia, M., Bottex, B., Abrahantes, J. C., & Schlatter, J.
Venue
EFSA Journal
Publisher
Wiley
Published
2022-10
Volume
20
Issue
10
Pages
e07584-e07584
ISSN
1831-4732 (ISSN-L)
OpenAlex
W4307582512
Cited by
222
References
4
FWCI
20.00
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidance on the use of the benchmark dose approach in risk assessment. https://app.cochat.ai/papers/10.2903/j.efsa.2022.7584
The paper
EFSA Scientific Committee, More, S. J., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T. I., Hernández‐Jerez, A. F., Bennekou, S. H., Koutsoumanis, K., Lambré, C., Machera, K., Mennes, W., Mullins, E., Nielsen, S. S., Schrenk, D., Turck, D., Younes, M., Aerts, M., Edler, L., . . . Schlatter, J. (2022). Guidance on the use of the benchmark dose approach in risk assessment. EFSA Journal. https://doi.org/10.2903/j.efsa.2022.7584

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.